<span item_type="fundamental" item_id="40168188da4547957d1cba8d1115db6e" counter_id="ST/US/RMSL" env="prod"></span><span item_type="announcement" item_id="584612700566854529" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 7.454 K.</p><p>EPS: As of FY2025 Q3, the actual value is USD 0.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -2.153 M.</p><p></p><h3>Segment Revenue</h3><ul><li>Revenue for the three months ended September 30, 2025: $7,454</li><li>Revenue for the three months ended September 30, 2024: $37,260</li><li>Revenue for the nine months ended September 30, 2025: $12,278</li><li>Revenue for the nine months ended September 30, 2024: $122,735<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1412126/000121390025112640/ea0265930-10q_remsleep.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>Gross margin for the three months ended September 30, 2025: $7,426</li><li>Gross margin for the three months ended September 30, 2024: - $21,300</li><li>Gross margin for the nine months ended September 30, 2025: $11,650</li><li>Gross margin for the nine months ended September 30, 2024: $44,645</li><li>Net loss for the three months ended September 30, 2025: - $2,312,146</li><li>Net loss for the three months ended September 30, 2024: - $277,909</li><li>Net loss for the nine months ended September 30, 2025: - $2,685,406</li><li>Net loss for the nine months ended September 30, 2024: - $756,088<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1412126/000121390025112640/ea0265930-10q_remsleep.htm"></span></li></ul><h3>Operating Expenses</h3><ul><li>Professional fees for the three months ended September 30, 2025: $11,750</li><li>Professional fees for the three months ended September 30, 2024: $22,680</li><li>Professional fees for the nine months ended September 30, 2025: $47,300</li><li>Professional fees for the nine months ended September 30, 2024: $87,365</li><li>Compensation expense for the three months ended September 30, 2025: $2,197,000</li><li>Compensation expense for the three months ended September 30, 2024: $49,000</li><li>Compensation expense for the nine months ended September 30, 2025: $2,248,000</li><li>Compensation expense for the nine months ended September 30, 2024: $105,000</li><li>Development expenses for the three months ended September 30, 2025: $0</li><li>Development expenses for the three months ended September 30, 2024: $40,775</li><li>Development expenses for the nine months ended September 30, 2025: $18,700</li><li>Development expenses for the nine months ended September 30, 2024: $196,795</li><li>Lease expenses for the three months ended September 30, 2025: $4,968</li><li>Lease expenses for the three months ended September 30, 2024: $18,255</li><li>Lease expenses for the nine months ended September 30, 2025: $31,459</li><li>Lease expenses for the nine months ended September 30, 2024: $69,179</li><li>General and administrative expenses for the three months ended September 30, 2025: $76,977</li><li>General and administrative expenses for the three months ended September 30, 2024: $42,105</li><li>General and administrative expenses for the nine months ended September 30, 2025: $213,327</li><li>General and administrative expenses for the nine months ended September 30, 2024: $201,501<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1412126/000121390025112640/ea0265930-10q_remsleep.htm"></span></li></ul><h3>Other Expenses</h3><ul><li>Total other expense for the three months ended September 30, 2025: $28,877</li><li>Total other expense for the three months ended September 30, 2024: $83,794</li><li>Total other expense for the nine months ended September 30, 2025: $138,270</li><li>Total other expense for the nine months ended September 30, 2024: $140,893<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1412126/000121390025112640/ea0265930-10q_remsleep.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>Cash used in operating activities for the nine months ended September 30, 2025: - $373,395</li><li>Cash used in operating activities for the nine months ended September 30, 2024: - $537,686</li><li>Cash used in investing activities for the nine months ended September 30, 2025: $0</li><li>Cash used in investing activities for the nine months ended September 30, 2024: - $73,700</li><li>Cash provided by financing activities for the nine months ended September 30, 2025: $254,000</li><li>Cash provided by financing activities for the nine months ended September 30, 2024: $427,000<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1412126/000121390025112640/ea0265930-10q_remsleep.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li>The company plans to conduct clinical trials to test product effectiveness pending adequate financing.</li><li>The company aims to capture 10% of the market in the next 24 months.</li><li>The company will continue to finance its operations through debt and/or equity financing as needed.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1412126/000121390025112640/ea0265930-10q_remsleep.htm"></span></li></ul>

REMSleep Holdings, Inc. | 10-Q: FY2025 Q3 Revenue: USD 7.454 K